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Abstract
Background: There is a need for improved worldwide access to tissue iron quantification using T2* cardiovascular
magnetic resonance (CMR). One route to facilitate this would be simple in-line T2* analysis widely available on MR
scanners. We therefore compared our clinically validated and established T2* method at Royal Brompton Hospital
(RBH T2*) against a novel work-in-progress (WIP) sequence with in-line T2* measurement from Siemens (WIP T2*).
Methods: Healthy volunteers (n = 22) and patients with iron overload (n = 78) were recruited (53 males, median
age 34 years). A 1.5 T study (Magnetom Avanto, Siemens) was performed on all subjects. The same mid-ventricular
short axis cardiac slice and transaxial slice through the liver were used to acquire both RBH T2* images and WIP T2*
maps for each participant. Cardiac white blood (WB) and black blood (BB) sequences were acquired. Intraobserver,
interobserver and interstudy reproducibility were measured on the same data from a subset of 20 participants.
Results: Liver T2* values ranged from 0.8 to 35.7 ms (median 5.1 ms) and cardiac T2* values from 6.0 to 52.3 ms
(median 31 ms). The coefficient of variance (CoV) values for direct comparison of T2* values by RBH and WIP were
6.1–7.8 % across techniques. Accurate delineation of the septum was difficult on some WIP T2* maps due to
artefacts. The inability to manually correct for noise by truncation of erroneous later echo times led to some
overestimation of T2* using WIP T2* compared with the RBH T2*. Reproducibility CoV results for RBH T2* ranged from
1.5 to 5.7 % which were better than the reproducibility of WIP T2* values of 4.1–16.6 %.
Conclusions: Iron estimation using the T2* CMR sequence in combination with Siemens’ in-line data processing is
generally satisfactory and may help facilitate global access to tissue iron assessment. The current automated T2* map
technique is less good for tissue iron assessment with noisy data at low T2* values.
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Background
Accurate and robust measurement of myocardial iron
stores is essential for preventing cardiac disease and
managing chelation treatment in patients with thalas-
semia, sickle cell disease, aplastic anemia, myelodyspla-
sia, and other transfusion-dependant anemias [1–3].
T2* cardiovascular magnetic resonance (CMR) is effect-
ive and robust for tissue iron measurement in myocar-
dial siderosis [4–8]; it is non-invasive and now
considered the method of choice for myocardial and
liver iron quantification [1, 9]. The underlying mechan-
ism is that MR relaxation time of hydrogen nuclei falls
with increasing amounts of storage iron. In recent stud-
ies, it has been demonstrated that tissue iron is the
dominant determinant of myocardial relaxation, indi-
cating that T2* CMR can measure the iron content
accurately [10, 11].
The development of T2* CMR has made a great
impact on patient management and survival, as no alter-
native method (e.g., serum ferritin, myocardial biopsy,
liver biopsy or susceptometry) gives reliable information
about cardiac iron loading. In the UK where it was first
introduced clinically, >70 % reductions in cardiac
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mortality for thalassemia major (TM) have been docu-
mented [12]. However, barriers to using T2* CMR exist.
Despite the successful T2* development, a recent inter-
national survey [13] indicates that the adoption of this
technique is heterogeneous and that cases of high liver/
myocardial iron concentration are still abundant, espe-
cially in developing countries where most of the patients
are located. Apart from sequence and practical imaging
issues, one particular challenge is that a post-processing
step of T2* measurement using special software and
training is required, resulting in some centers being un-
able to offer this lifesaving technique on a routine basis,
or using locally developed software which has not been
validated.
After a decade of development, the single breath-hold
multi-echo gradient CMR T2* sequence is available from
the major vendors, including Siemens, Philips and GE.
One recent approach to further increasing T2* access is
the vendors’ attempt to develop an in-line processing al-
gorithm to generate T2* maps immediately after the
scan. This obviates the need for third-party software,
with users being able to simply draw a region-of-interest
(ROI) on the map generated in the scanner console. This
may streamline clinical workflow with the additional ad-
vantage of decreased user interaction. One such product
is provided by Siemens Healthcare (Erlangen, Germany),
named the Works in Progress T2* package (WIP). How-
ever, there are little validation data on this type of poten-
tially useful product. In this study therefore, we aimed to
directly compare WIP T2* with the established T2*
technique at Royal Brompton Hospital (RBH) on a
population of healthy volunteers and patients with iron
overload conditions.
Methods
Patient population
A total of 22 healthy volunteers and 78 patients were re-
cruited (N = 100, 53 males, aged 13 to 81 years, median
34 years). Among patients referred for routine iron assess-
ment, there were 39 with beta-thalassaemia major, 15 with
sickle cell disease, 10 with hereditary hemochromatosis,
and 14 with other iron overload conditions. The study was
approved by the North-West Thames Ethics Committee.
All participants gave written informed consent.
MR protocols
All participants were scanned on a 1.5 T scanner
(Magnetom Avanto, Siemens Healthcare, Erlangen,
Germany) equipped with high performance gradients
and a six-element cardiac phased array coil and a spine
array coil. The same mid-ventricular short axis cardiac
slice and transaxial slice through the liver were used for
both RBH T2* images (developed in-house based on the
Siemens CV sequence) and WIP T2* (Siemens WIP 448,
VB17) maps for each participant. Cardiac white blood
(WB) and black blood (BB) and liver sequences [14, 15]
were all acquired for every patient. For RBH and WIP T2*
sequences, major parameters were set to be identical or
very close as optimised for each participant individually,
as previously described [14, 15] and according to our
clinical practice.
For the heart, a single 10 mm mid-ventricular short
axis slice was imaged at eight echo-times (ranging from
1.5 ms to 16.9 ms, increment 2.18 ms). The BB se-
quences used double inversion recovery pulses to sup-
press the blood signal and data were acquired every
other cardiac cycle, which made the effective sequence
two cardiac cycles long. For the liver, a mid-liver trans-
verse slice was acquired positioned to cover both lobes
using the sequence optimised for liver iron load with the
following acquisition parameters: flip angle of 20°, repe-
tition time of 200 ms, 12 echo times (0.93, 2.27, 3.61,
4.95, 6.29, 7.63, 8.97, 10.4, 11.8, 13.2, 14.6, 16 ms), slice
thickness of 10 mm. Fat saturation was applied and the
liver images were acquired within a breath-hold of ap-
proximately 13 s.
T2*measurement
For all cardiac analyses, a homogeneous full thickness
ROI was drawn in the septum. Care was taken to exclude
epicardial structures and blood pool from the contours.
For all liver analyses, three large ROIs (each >3 cm2) were
drawn in homogenous areas of liver parenchyma, exclud-
ing blood vessels.
For RBH T2* measurement, the mean signal inten-
sity of ROIs was measured in the series of increasing
TE images, and the data were plotted against each TE
to form an exponential decay curve. Truncation was
used to account for the plateau observed due to low
signal to noise ratio (SNR) at the later echo times.
All T2* measurements were carried out on a personal
computer using Thalassemia-Tools, a plug-in of
CMRtools (Cardiovascular Imaging Solutions, London,
UK). For WIP T2* measurement, like-for-like ROIs
were directly drawn on the magnitude images and
copied to the T2* maps generated on the scanner and
the mean ROI values were calculated for T2*. This
was performed because of the difficulty of confidently
identifying the myocardium on some T2* maps.
In order to evaluate the intra and inter-observer repro-
ducibility, all in-vivo data (n = 20) were ordered ran-
domly. For the intra-observer reproducibility, all selected
data were blindly reanalyzed by the same operator after
15 days. For the interobserver reproducibility, the data
were analyzed by two independent operators blinded to
each other’s T2* measurement. For interstudy reproduci-
bility, repeated scans performed on the same day, were
analyzed by the same observer blindly.
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Artefact scoring was performed using a 6 point scale
as previously described [16]. In brief, the analysis was
conducted using the following scale: 0- Very poor image
quality with unusable images; 1- Poor image quality, just
able to make out the heart/liver but a lot of artefact;
2- Average image quality, not all of septum/liver
clearly seen and a lot of artefact; 3- Good image
quality with moderate septal/liver artefact; 4- Very
good quality, with minimal septal/liver artefacts; 5-
Excellent image quality with no significant septal/liver
artefact. Higher scores indicated fewer artefacts with
higher image quality.
Statistics
Reproducibility analyses were assessed using the mean
and standard deviation (SD) of the differences as de-
scribed by the Bland-Altman analysis. The coefficient
of variation (CoV), defined as the SD of the differ-
ences between two independent measurements di-
vided by their means and expressed as a percentage,
was used to assess the intra- and inter-observer and
inter-study variability. Summary data were expressed
using the mean or median for normal and non-
normal data respectively. Correlation analysis was per-
formed using Pearson’s test. R2 was used to describe
how well the exponential model fitted the empirical
data. Wilcoxon signed rank test was used for artefact
score comparison. A p value of <0.05 was considered
statistically significant.
Results
All participants underwent scans without complications
and all scans were successfully analyzed. No data was ex-
cluded from analysis. Liver T2* values ranged from
0.8 ms to 35.7 ms (median 5.1 ms) and cardiac T2*
values from 6.0 ms to 52.3 ms (median 31 ms), both
representing a wide spectrum of tissue iron loading con-
ditions. Representative images acquired from a TM pa-
tient of the same mid-ventricular slice for RBH T2* and
WIP T2* are shown in Fig. 1. When considering all par-
ticipant images, four issues were noted: (A) all images of
both RBH and WIP T2* were diagnostic; (B) there were
generally more artefacts in WIP T2* maps than on the
RBH T2* images, which was attributable to the conse-
quences of the fitting; (C) delineation of the septum was
sometimes difficult in cardiac WIP T2* maps due to
poor contrast and artefacts; (D) in severely iron loaded
cases, there were “black holes” in some liver WIP T2*
maps, meaning that the mapping algorithm failed to
produce reasonable T2* values for these pixels.
Relation between RBH and WIP T2*measurements
For heart WB T2*, there was a linear correlation (Fig. 2,
R2 = 0.97, CoV = 6.1 %) between RBH and WIP tech-
niques. For heart BB T2*, the correlation is shown in
Fig. 3 (R2 = 0.95, CoV = 7.3 %). For liver T2*, the linear
correlation between RBH and WIP T2* techniques is
shown in Fig. 4 (R2 = 0.99, CoV = 7.8 %).
Interobserver, intraobserver, and interstudy reproducibility
The results of the reproducibility studies are summa-
rized in Table 1. For RBH T2*, the reproducibility was
good with the CoV ranging from 1.5 to 5.7 % which
compared with WIP T2* values which were less good,
being 4.1–16.6 %. An example of the difficulty in confi-
dently delineating the septum on the WIP T2* map is
shown in Fig. 5.
Artefact scoring
The artefact scores are shown in Table 1. There were
more artefacts with the white blood heart sequence,
compared to the black blood sequence (p < 0.001). There
were also some differences between the WIP and RBH
techniques in artefact scores, with RBH better for the
white blood heart sequence (p < 0.001).
Discussion
There is a need for improved access to T2* CMR and
more effort is needed to achieve this goal. Among these
efforts, a dedicated T2* sequence combined with in-line
processing has the promise to simplify T2* analysis and
enable confident T2* measurement in less experienced
centers. In this validation study, comparison of the RBH
T2* values (being used as a gold-standard) and the WIP
Fig. 1 Typical short axis mid-ventricular slices obtained from a thalassemia patient (left- RBH T2* sequence; middle- WIP sequence; right-
corresponding in-line T2* map)
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T2* values at 1.5 T showed good general agreement for
heart and liver with clinically acceptable variances of 6.1
to 7.8 %. Our data suggest that the automated WIP tech-
nique may prove useful in clinical practice.
Reproducibility of the RBH T2* and WIP techniques
showed that the RBH T2* analyses had reproducibility
that was in the region of 2-fold superior (Table 1). The
image quality of WIP T2* was generally good and this
suggests that the performance of the automated in-line
processing algorithm was probably suboptimal. We attri-
bute this mainly to the problems encountered in some
cases in correctly specifying the full thickness septum
Fig. 2 Scatter plot with the line of identity (left) and Bland-Altman plot (right) showing the comparison for the white blood RBH and WIP
T2* cardiac sequences. The 95 % confidence intervals are shown as dotted lines on the Bland-Altman plots
Fig. 3 Scatter plot with the line of identity (left) and Bland-Altman plot (right) showing the comparison for the black blood RBH and WIP
T2* cardiac sequences. The 95 % confidence intervals are shown as dotted lines on the Bland-Altman plots
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ROI on the T2* WIP map, as illustrated in Fig. 5. The
artefact scores were usually higher for the RBH T2*
technique indicating fewer artefacts with the RBH tech-
nique, but the differences overall were small. An issue
which affected comparability was the “black holes”
which occurred in some T2* maps with low T2* values,
where the WIP analysis algorithm failed to assign a T2*
value to the associated pixels and assigned a zero value,
which led to a reduced T2* for the ROI. These issues
may be addressed for improved performance in future
releases of the WIP technique. Nevertheless, according
to the Bland-Altman analyses, agreement between WIP
techniques and gold-standard RBH sequence seemed
highest in the ranges of particular clinical interest when
myocardial T2* was below 20 ms and in liver T2* was
below 5 ms.
There have been considerable efforts in parameter
mapping development at the pixel level for tissue char-
acterisation using CMR [17, 18]. The challenge is that
there is no in-vivo gold standard for this pixel-wise
approach due to the problem of motion [19, 20]. For this
reason, the validation itself is often reduced to a conven-
tional ROI based method, namely a ROI drawn in the
map instead of a real pixel-wise validation. For tissue
iron quantification using T2*, particular caution should
be taken for clinical use of this pixel-wise approach.
First, with inherently low SNR images compounded by
the well-known Rician noise distribution, the pixel-wise
T2* measurement error can amount to 150 % for the
unprocessed data [18]. Second, although using an ROI
on a pixel map can reduce the measurement error, this
approach has not been scientifically justified. In brief, a
pixel-wise mapping techniques are theoretically appeal-
ing, but meaningful measurements can only be made if
the map is accurate.
There are limitations to this study. Cardiac T2* mea-
surements were based on imaging and analysing the
septum, as myocardial T2* can only be measured reliably
in this region due to susceptibility artefacts. However,
mid-ventricular septal T2* is highly representative of
Fig. 4 Scatter plot with the line of identity (left) and Bland-Altman plot (right) showing the comparison for the RBH and WIP T2* liver sequences.
The 95 % confidence intervals are shown as dotted lines on the Bland-Altman plots
Table 1 Reproducibility data
Sequence Intraobserver Interobserver Interstudy Artefact score
CoV (%) CoV (%) CoV (%) (mean)
RBH/WIP RBH/WIP RBH/WIP RBH/WIP
1.5 T Heart White blood 3.2/5.1 3.3/10.4 5.5/9.3 4.25/3.27
1.5 T Heart Black blood 1.5/4.1 2.8/10.1 4.6/7.5 4.39/4.24
1.5 T Liver 2.0/6.1 4.2/16.6 5.7/10.2 4.06/4.06
CoV coefficient of variance, RBH Royal Brompton Hospital, WIP work-in-progress
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global iron concentration [21], and there is no significant
segmental variation of iron deposition across the heart
[21]. For the liver, it is generally accepted that iron distri-
bution is relatively homogeneous, but we only measured
T2* in a small region. Another limitation is that only a
single vendor of Siemens was selected in this study. A fu-
ture study of multi-vendor validation is warranted.
Conclusion
There have been significant technical advances in T2*
CMR over recent years and it is now the method of
choice for cardiac and hepatic iron quantification in
clinical practice. T2* sequence in combination with ven-
dor’s inline data processing development has the prom-
ise to improve global access to tissue iron assessment.
However, due to their inherent vulnerability to low SNR,
current T2* mapping and inline analysis techniques are
not yet fully optimised for tissue iron assessment. Fur-
ther scientific development is needed to improve the
mapping technique, which should be followed by valid-
ation in a large patient cohort.
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